Trial Profile
A Randomized, Open Label, Dose Titration Study to Evaluate the Efficacy and Safety of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms ESPRIT
- Sponsors JW Pharmaceutical
- 29 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual patient number is 161 according to ClinicalTrials.gov.